谷歌浏览器插件
订阅小程序
在清言上使用

Survival Outcomes for Right- Versus Left-Sided Colon Cancer and Rectal Cancer in Patients Receiving Regorafenib And/or Trifluridine/tipiracil for Refractory Metastatic Colorectal Cancer: Findings from the Multicenter Retrospective ReTrITa Study.

Journal of Clinical Oncology(2025)

引用 0|浏览3
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要